Furthermore, we found that the mutation rate of MTTP rs2306986 (c.294G>C, p.E98D) and SLC6A2 rs3743788 (c.1646T>C,p.I549T) was significantly higher in subjects with NAFLD than that without NAFLD. This evidence concerns the gene SLC6A2 and metabolic dysfunction-associated steatotic liver disease.